Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
231 studies found for:    Open Studies | "Fever"
Show Display Options
Rank Status Study
21 Recruiting Q Fever and Auto-immunity
Conditions: Q Fever;   Auto-Immunity
Intervention: Biological: Blood sampling
22 Recruiting Ketotifen as a Treatment for Vascular Leakage During Dengue Fever
Conditions: Dengue Fever;   Pleural Effusion
Interventions: Drug: Ketotifen;   Drug: Placebo
23 Not yet recruiting Ilaris (Canakinumab) in Patient With Periodic Fever, Aphthous Stomatitis, Pharyngitis and Cervical Adenitis (PFAPA)
Condition: Periodic Fever
Intervention: Drug: Canakinumab
24 Not yet recruiting Short vs Prolonged Antibiotic Treatment for Hospitalized Hemato-oncology Patients With Febrile Neutropenia
Conditions: Fever;   Febrile Neutropenia
Interventions: Drug: Piperacillin/tazobactam;   Drug: Ceftazidim;   Drug: Meropenem;   Drug: Vancomycin
25 Not yet recruiting Use of Malaria Rapid Diagnostic Tests as a Decision Aid for the Management of Fever by International Travelers
Conditions: Fever;   Malaria
Intervention: Device: rapid diagnostic test for malaria antigen
26 Recruiting Yellow Fever Vaccine on Statin/ Non Statin Subjects
Conditions: Yellow Fever Vaccine;   Yellow Fever
Intervention: Drug: Stamaril (live attenuated yellow fever vaccine)
27 Recruiting Improving the Diagnosis of Traveller's Fevers in Point Of Care (POC)
Condition: Traveller's Fever
Intervention: Other: Rectal Swab
28 Recruiting Risk Factors & Outcomes for Clinically Documented Infections in Pediatric Cancer Patients With Fever & Neutropenia
Condition: Febrile Neutropenia
Intervention:
29 Recruiting The Pilot Study of Chikungunya Virus Infections in Southern Taiwan
Condition: Chikungunya Fever
Intervention:
30 Recruiting Nepal Undifferentiated Febrile Illness Trial
Condition: Undifferentiated Febrile Illness
Interventions: Drug: Azithromycin;   Drug: Co-trimoxazole
31 Recruiting Investigating Enteric Fever - Salmonella Typhi and Paratyphi Challenge Study
Conditions: Typhoid Fever;   Paratyphoid Fever
Interventions: Biological: Salmonella Typhi;   Biological: Salmonella Paratyphi
32 Recruiting Clinical Research for the Diagnosis of Tick-borne Diseases in Patients With Unexplained Acute Fever
Conditions: Fever of Unknown Origin;   Tick-borne Diseases
Intervention: Other: diagnostic methods
33 Not yet recruiting Safety and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients
Conditions: Pain;   Fever
Intervention: Drug: Ibuprofen
34 Recruiting Malignant Hyperthermia Registry and Genetic Testing
Condition: Malignant Hyperthermia
Intervention:
35 Not yet recruiting Measuring the Metabolic Cost of Fever
Conditions: Child;   Critical Illness;   Fever
Intervention: Device: Indirect calorimetry
36 Recruiting Procalcitonin (PCT) as a Diagnostic Marker of Bacterial Infection in the Patients Admitted for Fever and/or Inflammatory Syndrome to the Internal Medicine Department
Conditions: Systemic Inflammatory Response Syndrome;   Fever
Intervention: Biological: Procalcitonin (PCT) as a diagnostic marker of bacterial infection
37 Recruiting A Two-step Method Apparently Improved the Physicians' Level of Diagnosis Decision-making for Adult Patients With FUO
Condition: Fever of Unknown Origin
Intervention: Other: Two-step diagnostic strategy
38 Recruiting A Case Control Study of Patients With Diagnosis of Malignant Hyperthermia
Condition: Malignant Hyperthermia
Intervention:
39 Recruiting A Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies
Conditions: Systemic Juvenile Idiopathic Arthritis;   Hereditary Periodic Fevers
Intervention: Drug: canakinumab
40 Recruiting Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO
Conditions: Febrile Neutropenia;   Hematological Malignancy
Intervention: Drug: Discontinuation of imipenem-cilastatin or meropenem

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.